LABT

Conviction 0HealthcareScan · Mon, Aug 10, 2026

LABT$2.32+4.50%

ResistanceSupportVol 14

Vol MA14 5.98M

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest +100.00%· 2 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Lakewood-Amedex Biotherapeutics Inc.Biotechnologylakewoodamedex.com ↗

Price2.32

Change+4.50%

Gap+0.23%

Rel volume0.00×

Avg volume4.26M

Avg $ vol14.29M

SMA 202.28

SMA 502.04

SMA 200—

Price vs 50+13.71%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 3.64

RSI (14)50

MACD hist-0.01

MACD crossbear · 9d

Stoch %K / %D10 / 10

ADX (14)34

+DI / −DI42 / 18

RSI divergence—

MACD divergenceBearish

ATR %+21.46%

ADR %19.88%

52w high8.65

52w low0.3861

From 52w high-73.18%

Above 52w low+500.88%

New 52w highNo

SqueezeOn · 10d

Bollinger width69.43%

%B0.52

Donchian pos12.72%

Donchian high6.85

Donchian low1.66

AVWAP (52w high)3.36

vs AVWAP high-30.95%

AVWAP (52w low)4.16

vs AVWAP low-44.19%

OBV trendUp

Chaikin MF (20)-0.75

Today vs 20d0.00×

Avg vol (14d)5.98M

Avg vol (20d)4.26M

Avg $ vol (20d)14.29M

Market cap—

RS 3m (vs SPY)-38.42%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank48.4

1 week+7.41%

1 month-11.11%

3 months-25.16%

6 months—

1 year—

YTD-73.18%

P/E—

P/B-5.44

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current0.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional0.00%

Ent. value15.45M

Revenue—

Net income-923.29K

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out14.32M

Employees—

ListedThu, Apr 23, 2026

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank48.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.79

Support1.01

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LABT

All disclosures →

No recent disclosed trades by Congress in LABT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LABT · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Tucker Joseph Edward Director · Warrant to acquire Common Stock · 2026-04-24	Grant	33.78K	$0	2026-04-24	2026-05-06

SEC filings

EDGAR filings in LABT · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.